関連する実験動画

Updated: Feb 17, 2026

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
04:40

Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models

Published on: January 5, 2024

3.3K

遺伝的に予測されたマノース結合レクチン (MBL) レベルと将来の静脈血栓塞栓症のリスク - The HUNT Study

Christabel Esi Damoah1, Birgitte Tøndel1, Omri Snir2

  • 1Thrombosis Research group (TREC), Department of Clinical Medicine, UiT - the Arctic University of Norway, Tromsø, Norway.

Journal of thrombosis and haemostasis : JTH
|February 15, 2026
PubMed
まとめ

遺伝的に予測されたマノース結合レクチン (MBL) レベルは,若い男性における静脈血栓塞栓症 (VTE) リスクの高さに関連しています. この関連性は,性別と年齢によって影響されているようで,高齢の男性や女性では有意な関連性が見つかりませんでした.

キーワード:
深い静脈の血栓症である.レクチン補完経路は,レクチン補完経路である.マノースを結合するレクチン肺栓塞 (肺栓塞) とは,肺栓塞 (肺栓塞) とは,肺栓塞 (肺栓塞) とは,肺栓塞のことです.静脈性血栓塞栓症 静脈性血栓塞栓症 静脈性血栓塞栓症 静脈性血栓塞栓症 静脈性血栓塞栓症静脈血栓症 (Venous thrombosis) とは,静脈の血栓が形成され,静脈の血栓が形成され,静脈の血栓が形成される.

さらに関連する動画

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis04:34

Mouse Complete Stasis Model of Inferior Vena Cava Thrombosis

Published on: June 15, 2011

19.0K
A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis10:26

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis

Published on: June 2, 2015

18.0K

関連する概念動画

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
355
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
504
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.8K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
383
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
9